Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring

Nephrology

Volumn 17, Issue 2, 2012, Pages 182-188

  Vos, Frederiek E ^a   Schollum, John B ^a   Coulter, Carolyn V ^b   Manning, Patrick J ^a   Duffull, Stephen B ^b   Walker, Robert J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

chronic kidney disease; continuous glucose monitoring; glycaemic control; glycated albumin; glycated haemoglobin

Indexed keywords

BIOLOGICAL MARKER; FRUCTOSAMINE; GLUCOSE; GLYCOSYLATED ALBUMIN; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTINUOUS BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET RESTRICTION; FEMALE; GLOMERULUS FILTRATION RATE; GLYCEMIC CONTROL; HEMODIALYSIS; HUMAN; LIFESTYLE MODIFICATION; MALE; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; PRIORITY JOURNAL;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHRONIC DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; NEW ZEALAND; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84856145413     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01517.x     Document Type: Article

References (39)

1. Alberti K, Zimmet P,. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 1998; 15: 539-53. (Pubitemid 28319935)
2. Collins AJ, Foley RN, Herzog C, et al,. Excerpts from the US Renal Data System. Annual Data Report. Am. J. Kidney Dis. 2009; 55: S1-420.
3. DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus: The diabetes control and complications trial research group. N. Engl. J. Med. 1993; 329: 977-86.
4. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR,. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003; 63: 225-32. (Pubitemid 35463925)
5. Bunn H, Haney D, Kamin S, Gabbay K, Gallop P,. The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo. J. Clin. Invest. 1976; 57: 1652-59.
6. Fauci AS, Braunwald E, Kasper D, Hauser S, Longo DLL, Loscalzo J,. Harrison's Principles of Internal Medicine, 17th edn. New York: McGraw-Hill Companies.Inc, 2008.
7. Vos FE, Schollum JB, Coulter CV, Doyle TCA, Duffull SB, Walker RJ,. Red blood cell survival in patients on long-term dialysis. Am. J. Kidney Dis. 2011. [doi:10.1053/j.ajkd.2011.03.031, Epub ahead of print].
8. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE,. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002; 25: 275-8. (Pubitemid 41079621)
9. Nathan DM, Turgeon H, Regan S,. Relationship between glycated haemoglobin levels and mean glucose levels over time. Diabetologia 2007; 50: 2239-44. (Pubitemid 47512407)
10. Agarwal R, Light RP,. Relationship between glycosylated hemoglobin and blood glucose during progression of chronic kidney disease. Am. J. Nephrol. 2011; 34: 32-41.
11. Joske R, McAlister J, Prankerd A,. Isotope investigations of red cell production and destruction in chronic renal disease. Clin. Sci. 1956; 15: 511-22.
12. Ly J, Marticorena R, Donnelly S,. Red blood cell survival in chronic renal failure. Am. J. Kidney Dis. 2004; 44: 715-9. (Pubitemid 39237616)
13. Nakao T, Matsumoto H, Okada T, et al,. Influence of erythropoietin treatment on hemoglobin A1c levels in patients with chronic renal failure on hemodialysis. Intern. Med. 1998; 37: 826-30.
14. KDOQI. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am. J. Kidney Dis. 2007; 49: S12-154.
15. Garlick R, Mazer J,. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J. Bio. Chem. 1983; 258: 6142-46. (Pubitemid 13106789)
16. Tahara Y, Shima K,. Kinetics of HbA1c, glycated albumin, and fructosamine and analysis of their weight functions against preceding plasma glucose level. Diabetes Care 1995; 18: 440-7.
17. Armbruster DA,. Fructosamine: structure, analysis, and clinical usefulness. Clin. Chem. 1987; 33: 2153-63.
18. Chujo K, Shima K, Tada H, et al,. Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA). J. Med. Invest. 2006; 53: 223-8. (Pubitemid 44619840)
19. Freedman BI, Shenoy RN, Planer JA, et al,. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit. Dial. Int. 2010; 30: 72-9.
20. Inaba M, Okuno S, Kumeda Y, et al,. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 2007; 18: 896-903. (Pubitemid 46434506)
21. Peacock T, Shihabi Z, Bleyer A, et al,. Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis. Kidney Int. 2008; 73: 1062-68. (Pubitemid 351543905)
22. Chico A, Vidal-Rios P, Subira M, Novials A,. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic control. Diabetes Care 2003; 26: 1153-7. (Pubitemid 36929264)
23. Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, et al,. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes. Diabetes Care 2009; 32: 1137-42.
24. Riveline JP, Teynie J, Belmouaz S, et al,. Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system. Nephrol. Dial. Transplant. 2009; 24: 2866-71.
25. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D,. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann. Intern. Med. 1999; 130: 461-70. (Pubitemid 29135798)
26. Kouzuma T, Usami T, Yamakoshi M, Takahashi M, Imamura S,. An enzymatic method for the measurement of glycated albumin in biological samples. Clin. Chim. Acta 2002; 324: 61-71. (Pubitemid 35245496)
27. Chen HS, Wu TE, Lin HD, et al,. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4. Am. J. Kidney Dis. 2010; 55: 867-74.
28. Djakoure-Platonoff C, Radermercker R, Reach G, Slama G, Selam JI,. Accuracy of the continuous glucose monitoring system in inpatient and outpatient conditions. Diabetes Metab. 2003; 29: 159-62. (Pubitemid 36576095)
29. Mak RH, DeFronzo RA,. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-82.
30. Brown JN, Kemp DW, Brice KR,. Class effect of erythropoietin therapy on hemoglobin A(1c) in a patient with diabetes mellitus and chronic kidney disease not undergoing hemodialysis. Pharmacotherapy 2009; 29: 468-72.
31. Pisoni RL, Bragg-Gresham JL, Young EW, et al,. Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 2004; 44: 94-111. (Pubitemid 38880932)
32. Freedman D, Dandona P, Fernando O, Moorhead JF,. Glycosylated haemoglobin in chronic renal failure and after renal transplantation. J. Clin. Pathol. 1982; 35: 737-9. (Pubitemid 12092658)
33. Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM,. Tests of glycemia in diabetes. Diabetes Care 1995; 18: 896-909.
34. Lamb E, Mainwaring-Burton R, Dawnay A,. Effect of protein concentration on the formation of glycated albumin and fructosamine. Clin. Chem. 1991; 37: 2138-9.
35. Schleicher ED, Olgemoller B, Wiedenmann E, Gerbitz KD,. Specific glycation of albumin depends on its half-life. Clin. Chem. 1993; 39: 625-8. (Pubitemid 23118312)
36. Kunika K, Itakura M, Yamashita K,. Correction of fructosamine value for serum albumin and globulin concentrations. Diabetes Res. Clin. Pract. 1991; 13: 37-44.
37. Ichikawa H, Nagake Y, Takahashi M, et al,. What is the best index of glycemic control in patients with diabetes mellitus on hemodialysis? Nippon Jinzo Gakkai Shi 1996; 38: 305-8. (Pubitemid 126496398)
38. Joy MS, Cefalu WT, Hogan SL, Nachman PH,. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am. J. Kidney Dis. 2002; 39: 297-307. (Pubitemid 34174252)
39. Amore A, Cirina P, Conti G, et al,. Amadori-configurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol. Dial. Transplant. 2004; 19: 53-60. (Pubitemid 38072615)